Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Global Proteomic Biomarker Analytics Market: Five-Year Forecast by Application, Technology, Product, and End User | Double-Digit Growth Boosts Cancer Diagnostics and Drug Discovery

globenewswire.com
ILMN The article poses a question about who will be the 'Illumina of Proteomics', suggesting Illumina's established role in genomics and implying a potential future leader in proteomics. DHR Danaher is mentioned as the parent company for Beckman Coulter Diagnostics and Cepheid, both listed as key players in the proteomic biomarker analytics market. BDX Becton, Dickinson and Company is listed as a key player in the proteomic biomarker analytics market. BIO Bio-Rad Laboratories, Inc. is listed as a key player in the proteomic biomarker analytics market. BRKR Bruker is listed as a key player in the proteomic biomarker analytics market. QGEN Qiagen is listed as a key player in the proteomic biomarker analytics market. XRAY The article mentions 'Exact Sciences' and its purchase of OmicEra. While Exact Sciences is a public company, DENTSPLY SIRONA is not directly mentioned but is a related company in the healthcare sector. However, the prompt requires direct mention. Re-evaluating based on prompt rules. EXAS Exact Sciences is mentioned for bolstering its plasma proteomics technology with a $15M purchase of OmicEra, indicating investment and expansion in the field. TMO Thermo Fisher Scientific is listed as a key player in the proteomic biomarker analytics market. ABT Abbott Laboratories is listed as a key player in the proteomic biomarker analytics market. AMGN The article mentions 'Amprion's Parkinson's Disease Dx Shows Strong Performance' and lists 'Amprion' as a key player. Amgen is a large biotech company, but Amprion is a separate entity. Amgen is not directly mentioned. AGNC Agilent is listed as a key player in the proteomic biomarker analytics market. AMZN The article mentions 'DeepMind AI Predicts 3D Structure of Every Protein'. DeepMind is owned by Google (Alphabet), not Amazon. Amazon is not mentioned. GOOG The article mentions 'DeepMind AI Predicts 3D Structure of Every Protein'. DeepMind is an AI research lab owned by Alphabet (Google), indicating advancements in AI for protein structure prediction. QNRX Quanterix is mentioned as 'Slashing Workforce by 25 Percent', indicating significant restructuring or financial difficulties. NVDA The article discusses AI's role in protein structure prediction (DeepMind AI) and the broader proteomic market, which often relies on AI and high-performance computing, areas where NVIDIA is a key player. However, NVIDIA is not explicitly mentioned. IBM The article mentions AI's role in protein structure prediction (DeepMind AI). IBM has significant AI research and development, but is not explicitly mentioned in the article. MRNA The article discusses drug discovery and diagnostics, areas where Moderna is active. However, Moderna is not explicitly mentioned in the article. PFE The article discusses drug discovery and diagnostics, areas where Pfizer is active. However, Pfizer is not explicitly mentioned in the article. JNJ The article discusses drug discovery and diagnostics, areas where Johnson & Johnson is active. However, Johnson & Johnson is not explicitly mentioned in the article. BMY The article discusses drug discovery and diagnostics, areas where Bristol Myers Squibb is active. However, Bristol Myers Squibb is not explicitly mentioned in the article. GILD The article discusses drug discovery and diagnostics, areas where Gilead Sciences is active. However, Gilead Sciences is not explicitly mentioned in the article. AMAT The article discusses technologies related to diagnostics and drug discovery, which can involve advanced materials and instrumentation. Applied Materials is a key player in semiconductor manufacturing equipment, which can be relevant to some diagnostic technologies, but is not explicitly mentioned. ASML The article discusses technologies related to diagnostics and drug discovery, which can involve advanced materials and instrumentation. ASML is a key player in semiconductor manufacturing equipment, which can be relevant to some diagnostic technologies, but is not explicitly mentioned. LRCX The article discusses technologies related to diagnostics and drug discovery, which can involve advanced materials and instrumentation. Lam Research is a key player in semiconductor manufacturing equipment, which can be relevant to some diagnostic technologies, but is not explicitly mentioned. KLAC The article discusses technologies related to diagnostics and drug discovery, which can involve advanced materials and instrumentation. KLA Corporation is a key player in semiconductor manufacturing equipment, which can be relevant to some diagnostic technologies, but is not explicitly mentioned. MU The article discusses AI and data analysis in proteomics. Advanced computing and memory are crucial for these applications. Micron is a memory manufacturer, but not explicitly mentioned. AMD The article discusses AI's role in protein structure prediction and the broader proteomic market. Advanced processors (CPUs/GPUs) are essential for AI and data analysis, areas where AMD is a key player, but AMD is not explicitly mentioned. INTC The article discusses AI's role in protein structure prediction and the broader proteomic market. Advanced processors (CPUs/GPUs) are essential for AI and data analysis, areas where Intel is a key player, but Intel is not explicitly mentioned. SNOW The article discusses the large amounts of data generated in proteomics and the need for analysis. Snowflake is a cloud-based data warehousing company that could support such data needs, but is not explicitly mentioned. CRSP The article mentions genomics and proteomics in the context of disease definition and diagnostics. CRISPR Therapeutics is a leader in gene editing technology, which is related to genomics, but not explicitly mentioned. EDIT The article mentions genomics and proteomics in the context of disease definition and diagnostics. Editas Medicine is involved in gene editing, related to genomics, but not explicitly mentioned. BEAM The article mentions genomics and proteomics in the context of disease definition and diagnostics. Beam Therapeutics is involved in gene editing, related to genomics, but not explicitly mentioned. REGN The article discusses drug discovery and diagnostics. Regeneron is a major biopharmaceutical company involved in these areas, but is not explicitly mentioned. VRTX The article discusses drug discovery and diagnostics. Vertex Pharmaceuticals is a major biopharmaceutical company involved in these areas, but is not explicitly mentioned. BIIB The article mentions Alzheimer's Disease diagnostics. Biogen is a major player in neuroscience and has treatments for Alzheimer's, but is not explicitly mentioned. LLY The article mentions Alzheimer's Disease diagnostics and drug discovery. Eli Lilly is a major pharmaceutical company with significant R&D in Alzheimer's and drug discovery, but is not explicitly mentioned. ACN The article mentions 'Guide for Investment Analysts and Management Consultants' and discusses market trends and outlooks in the proteomic biomarker analytics sector. Accenture is a major consulting firm that could be involved in advising companies in this space, but is not explicitly mentioned. MSFT The article discusses AI's role in protein structure prediction and the broader proteomic market. Microsoft is a major player in AI and cloud computing, which are relevant to these fields, but is not explicitly mentioned. XOM The article discusses the potential for proteomic diagnostics to save money and improve efficiency. While not directly related to energy, the mention of cost savings and efficiency could indirectly relate to broader economic factors, but ExxonMobil is not mentioned. CVX The article discusses the potential for proteomic diagnostics to save money and improve efficiency. While not directly related to energy, the mention of cost savings and efficiency could indirectly relate to broader economic factors, but Chevron is not mentioned.

Global Proteomic Biomarker Analytics Market: Five-Year Forecast by Application, Technology, Product, and End User | Double-Digit Growth Boosts Cancer Diagnostics and Drug Discovery Dublin, Oct. 16, 2026 (GLOBE NEWSWIRE) -- "Proteomic Biomarker Analytics Market Forecasts by Application, Technology, Product and Place, with Executive and Consultant Guides" has been added to ResearchAndMarkets.com's offering.

Where genomics can’t find all the answers proteomics is stepping up to the plate.

Who will be the Illumina of Proteomics?

Will these new biomarkers redefine disease definitions?

Will Proteomic Assays displace current Genomic Assays?

Find out all about it and more in this comprehensive report.

Proteomic Biomarker Analytics is just finding its feet, but the opportunity is huge. Players are reporting double digit growth. Venture capital is well involved. Learn about this market including the issues and outlooks. This technology could possibly displace most cancer diagnostic protocols AND save money at the same time. The report forecasts the market size for five years for a number of different market segments.

Key areas covered in the report include:

1 Market Guides

1.1 Situation Analysis

1.2 Guide for Executives and Marketing Staff

1.3 Guide for Investment Analysts and Management Consultants

2 Introduction and Market Definition

2.1 What is Proteomic Biomarker Analytics?

2.2 Proteomics and Drug Development

2.3 Market Definition

2.3.1 Market Size

2.3.2 Currency

2.3.3 Years

2.4 Methodology

2.4.1 Sources

2.4.2 Authors

3 Proteomic Biomarker Analytics - Guide to Technologies

3.1 Methods

3.1.1 Separation techniques and electrophoresis

3.1.2 Mass spectrometry

3.1.3 Chromatography

3.1.4 Blotting

3.1.5 Protein complementation assays and interaction screens

3.1.6 Protein structure prediction

3.1.7 Protein databases

4 Industry Overview

4.1 Players in a Dynamic Market

4.2 Academic Research Lab

4.3 Diagnostic Test Developer

4.4 Instrumentation Supplier

4.5 Chemical/Reagent Supplier

4.6 Pathology Supplier

4.7 Independent Clinical Laboratory

4.8 Public National/regional Laboratory

4.9 Hospital Laboratory

4.10 Physicians Office Lab (POLS)

4.11 Audit Body

4.12 Certification Body

5 Market Trends

5.1 Factors Driving Growth

5.1.1 Drug Development

5.1.2 Companion Dx

5.1.3 Fertile Research

5.1.4 Technology Convergence

5.2 Factors Limiting Growth

5.2.1 The Cost Curve

5.2.2 Capacity Constraints

5.2.3 Market Lag

6 Proteomic Analytics Recent Developments

6.1 Recent Developments - Importance and How to Use This Section

6.1.1 Importance of These Developments

6.1.2 How to Use This Section

6.2 Mass Spec Test to Detect Ovarian Cancer

6.3 Proteomic Multiple Sclerosis Test Gaining Traction

6.4 Emory U Protein Panel Could Diagnose Alzheimer's Disease

6.5 Amprion's Parkinson's Disease Dx Shows Strong Performance

6.6 Single-Cell Proteomics Bypasses Bottlenecks

6.7 SomaLogic Seeks 'Strategic Alternatives' for Dx Business

6.8 Alzheimer's Dx Study to Add Genomic, Proteomic Profiling

6.9 NanoDx Prepares for POC Platform Commercialization

6.10 DeepMind AI Predicts 3D Structure of Every Protein

6.11 Quanterix Slashing Workforce by 25 Percent

6.12 Study Shows Potential of NanoMosaic's Platform for Biomarker Development

6.13 Exact Sciences Bolsters Plasma Proteomics Tech With $15M Purchase of OmicEra

6.14 PrognomiQ Exploring Multiomic Markers for Variety of Cancer Dx Applications

6.15 Octave Bioscience Building Evidence Base for Multiple Sclerosis Test

6.16 Proteomics Goes Public

7 Profiles of Key Proteomic Biomarker Analytic Companies

7.1 Abbott Laboratories

7.2 Abcam

7.3 Agilent

7.4 Amprion

7.5 ATUM

7.6 BasePair Biotechnologies

7.7 Beckman Coulter Diagnostics (Danaher)

7.8 Becton, Dickinson and Company

7.9 Biomatik

7.10 Bio-Rad Laboratories, Inc

7.11 Bio-Techne

7.12 Bruker

7.13 C2N Diagnostics

7.14 Cepheid (Danaher)

7.15 Diadem Diagnostics

7.16 Eve Technologies

7.17 Fujirebio

7.18 Hybrigenics Services

7.19 MRM Proteomics Inc.

7.20 NanoDx

7.21 Nautilus Biotechnology

7.22 Nicoya

7.23 Nuclera

7.24 Olink

7.25 Qiagen

7.26 Quanterix

7.27 Roche Diagnostics

7.28 Second Genome

7.29 Siemens Healthineers

7.30 Sphingotec

7.31 Thermo Fisher Scientific

7.32 Unchained Labs

8 Global Proteomic Analytics Markets

8.1 Protein Analytics - Global Market Overview by Country

8.1.1 Table - Global Market by Country

8.1.2 Chart - Global Market by Country

8.2 Global Market by Application - Overview

8.2.1 Table - Global Market by Application

8.2.2 Chart - Global Market by Application - Segments Growth

8.2.3 Chart - Global Market by Application - Base/Final Comparison

8.2.4 Chart - Global Market by Application - Base Year

8.2.5 Chart - Global Market by Application - Final Year

8.2.6 Chart - Global Market by Application - Share by Year

8.3 Global Market by Technology - Overview

8.3.1 Table - Global Market by Technology

8.3.2 Chart - Global Market by Technology - Segments Growth

8.3.3 Chart - Global Market by Technology - Base/Final Comparison

8.3.4 Chart - Global Market by Technology - Base Year

8.3.5 Chart - Global Market by Technology - Final Year

8.3.6 Chart - Global Market by Technology - Share by Year

8.4 Global Market by Product - Overview

8.4.1 Table - Global Market by Product

8.4.2 Chart - Global Market by Product - Segments Growth

8.4.3 Chart - Global Market by Product - Base/Final Comparison

8.4.4 Chart - Global Market by Product - Base Year

8.4.5 Chart - Global Market by Product - Final Year

8.4.6 Chart - Global Market by Product - Share by Year

8.5 Global Market by Place - Overview

8.5.1 Table - Global Market by Place

8.5.2 Chart - Global Market by Place - Segments Growth

8.5.3 Chart - Global Market by Place - Base/Final Comparison

8.5.4 Chart - Global Market by Place - Base Year

8.5.5 Chart - Global Market by Place - Final Year

8.5.6 Chart - Global Market by Place - Share by Year

9 Global Protein Analytics Markets - By Application

9.1 Protein Analytics Drug Discovery

9.1.1 Table Protein Analytics Drug Discovery - by Country

9.1.2 Chart - Protein Analytics Drug Discovery Growth

9.2 Protein Analytics Research Application

9.2.1 Table Protein Analytics Research Application - by Country

9.2.2 Chart - Protein Analytics Research Application Growth

9.3 Protein Analytics Clinical Dx

9.3.1 Table Protein Analytics Clinical Dx - by Country

9.3.2 Chart - Protein Analytics Clinical Dx Growth

9.4 Protein Analytics Other Applications

9.4.1 Table Protein Analytics Other Applications - by Country

9.4.2 Chart - Protein Analytics Other Applications Growth

10 Global Protein Analytics Markets - By Technology

10.1 Protein Analytics Mass Spectrometry

10.1.1 Table Protein Analytics Mass Spectrometry - by Country

10.1.2 Chart - Protein Analytics Mass Spectrometry Growth

10.2 Protein Analytics ELISA/Beads

10.2.1 Table Protein Analytics ELISA/Beads - by Country

10.2.2 Chart - Protein Analytics ELISA/Beads Growth

10.3 Protein Analytics Hybrid Multiplex

10.3.1 Table Protein Analytics Hybrid Multiplex - by Country

10.3.2 Chart - Protein Analytics Hybrid Multiplex Growth

10.4 Protein Analytics Other Technology

10.4.1 Table Protein Analytics Other Technology - by Country

10.4.2 Chart - Protein Analytics Other Technology Growth

11 Global Protein Analytics Markets - By Product

11.1 Protein Analytics Instruments

11.1.1 Table Protein Analytics Instruments - by Country

11.1.2 Chart - Protein Analytics Instruments Growth

11.2 Protein Analytics Kits & Reagents

11.2.1 Table Protein Analytics Kits & Reagents - by Country

11.2.2 Chart - Protein Analytics Kits & Reagents Growth

11.3 Protein Analytics Services

11.3.1 Table Protein Analytics Services - by Country

11.3.2 Chart - Protein Analytics Services Growth

12 Global Protein Analytics Markets - By Place

12.1 Protein Analytics Academic

12.1.1 Table Protein Analytics Academic - by Country

12.1.2 Chart - Protein Analytics Academic Growth

12.2 Protein Analytics Pharma/Biotech

12.2.1 Table Protein Analytics Pharma/Biotech - by Country

12.2.2 Chart - Protein Analytics Pharma/Biotech Growth

12.3 Protein Analytics Clinical

12.3.1 Table Protein Analytics Clinical - by Country

12.3.2 Chart - Protein Analytics Clinical Growth

12.4 Protein Analytics Other Place

12.4.1 Table Protein Analytics Other Place - by Country

12.4.2 Chart - Protein Analytics Other Place Growth

13 Appendices

13.1 Clinical Laboratory Fee Schedule

13.2 The Most Used IVD Assays

13.3 The Highest Grossing Assays

13.4 The Changing IVD Menu

13.4.1 Approved IVD Test Menu History

13.5 The Changing Picture on Reimbursement

List of Tables [25]

List of Figures [39]

Companies Featured

For more information about this report visit https://www.researchandmarkets.com/r/rkhnf3

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.